Taken together, these results suggest that ZEB1 has a tumor-promoting effect in Kras-mutant models of intestinal tumorigenesis but, contrary to expectations, a tumor suppressive effect in Braf-mutant counterparts. This evidence concerns the gene KRAS and neoplasm.